Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21812672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Conditions: Immunosuppresion;   Thrombocytopenia;   Pancytopenia;   Neutropenia
Interventions: Biological: Anti-thymocyte globulin (rabbit);   Biological: Anti-thymocyte globulin (horse);   Drug: Cyclosporine

Indicates status has not been verified in more than two years